• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CLV

CLOVER CORPORATION LIMITED - Charts / Financials

1.82% ! 54.0¢
Market Cap $88.50M  !
Consumer Defensive Household & Personal Products
Add to My Watchlist

Clover Corporation Limited is focused on technology, new product development and... Clover Corporation Limited is focused on technology, new product development and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. The Company’s microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.More

refresh Created with Sketch. REFRESH
Last update - 15.59pm 26/06/2025 (20 minute delay) ?
Day
Open 55.0¢   Day High 57.0¢   Day Low 53.0¢
Daily Volume 179685
Bids   Sellers
Number Price Volume   Number Price Volume
2 53.0¢ 5212   1 55.0¢ 1600

Directors & Senior Management

Mr. Peter J. Davey Chief Executive Officer, Managing Director, Executive Director
Mr. Andrew Allibon Chief Financial Officer, Company Secretary
Mr. Rupert Harrington Non-Executive Chairman of the Board
Mr. Graeme Ambery Billings Independent Non-Executive Director
Ms. Toni L. Brendish Non-Executive Independent Director
Mr. Ian D. Glasson Non-Executive Independent Director
Dr. Simon P. Green Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
54.0¢ 		Change
-0.010(1.82%) 		Mkt cap ! $88.50M
Open High Low Value Volume
55.0¢ 57.0¢ 53.0¢ $99.13K 179.6K

Buyers (Bids)

No. Vol. Price($)
2 5212 53.0¢
 

Sellers (Offers)

Price($) Vol. No.
55.0¢ 1600 1
View Market Depth
Last trade - 15.59pm 26/06/2025 (20 minute delay) ?
Last
54.0¢ 		  Change
-0.010 ( 0.00 %)
Open High Low Volume
55.5¢ 55.5¢ 53.0¢ 23396
Last updated 15.59pm 26/06/2025 ?

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Late-stage drug developer Paradigm (ASX:PAR) is trending today after adding a new oral combination IP to its osteoarthritis drug stable. The acquisition came after the company paid $500,000 to buy up Proteobioactives.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 26 epis...
Australia’s gas crisis is here – and dying coal plants aren’t helping  The east coast of Australia is facing a looming gas shortage crisis. Just last week, the Australian state of Victoria...
'Not possible' to port renewable gas: ACCC takes AGN to court It's not just ASIC that has turned its focus to greenwashing in recent history. As pat of an existing greenwashing sting...
Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment Neuren Pharma (ASX:NEU) has seen its shares jump over +11% as the company wins a patent to treat Pitt Hopkins Syndrome...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.